Anti-Viral Therapies Market Size, Share, Growth Report 2032

According to the report published by Zion Market Research, the global Anti-Viral Therapies Market size was valued at USD 36.12 Billion in 2022 and is predicted to reach USD 51.244 Billion by the end of 2030. The market is expected to grow with a CAGR of 4.53% during the forecast period. The report analyzes the global Anti-Viral Therapies Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Anti-Viral Therapies industry.

Request Free Sample

Global Anti-Viral Therapies Market: Overview

Anti-viral therapy is an exciting part of virology, as it offers basic science to create very effective treatments for serious viral infections. Viral infections impose a socioeconomic burden, threaten public health, and leads to high mortality & morbidity. Anti-viral therapy is the best solution and also plays a crucial role in the management of neonatal and congenital viral infections.

Global Anti-Viral Therapies Market: Growth Factors

The global anti-viral therapies market is growing at a lucrative rate. Factors such as an increase in the burden of viral infections, the emergence of new strains & viruses resistant to available antivirals, and growing research & development activities are some of the factors that are propelling the growth of the global market. Further, the current outbreak of Covid-19 has led to a sudden boost in the demand for anti-viral therapies. The causative agent of Covid-19, SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), by far has infected over 29 million people that has led to nearly 900 000 deaths. Additionally, the re-emergence of some viruses, the emergence of new viruses, the limited number of antivirals available, and the high prevalence of viral infections, research on new and effective antivirals have become very crucial.

In addition to this, high genetic variations presented by some of the viruses have necessitated persistent monitoring for possible pandemics. In addition to this, globally, it is been projected that nearly 1.8 million people are infected with HIV. All these factors have led to a surge in the demand for anti-viral therapies thereby contributing to the growth of the global anti-viral therapies market. In addition to this, increase in preference for generic drugs, increase in the number of clinical trials for anti-viral therapies, rise in adoption of antiretroviral therapy, and increase in the funds to strengthen the pharmaceuticals clinical development pipeline are also some of the key aspects that are fueling the growth of the global market. Furthermore, the growing focus of the manufacturers on the development of investigational medicine for treating COVID-19 affected patients and the development of host-targeting antiviral therapies are likely to create numerous opportunities for the growth of the global anti-viral therapies market over the forecast period. However, the high cost associated with the anti-viral therapies may impede the growth of the global anti-viral therapies market.

The scenario of the entire world has been changed by the emergence of coronavirus disease of 2019 (COVID-19) pandemic. It has spread globally affecting millions of people at a rapid rate. Such a dreadful situation is demanding an efficient strategy to identify the drugs to treat the Covid-19 patients. Thus, there is a tremendous boost in the repurposing of antiviral drugs, and apart from this convalescent plasma therapy is used as a probable efficient antiviral strategy. In addition to this, increase in funds for antiviral therapies has been augmenting the growth of the global anti-viral therapies market during the pandemic and is anticipated to grow at a healthy rate in the upcoming years.

Request Free Sample

Global Anti-Viral Therapies Market: Segmentation

The global anti-viral therapies market is categorized based on mechanism of action, type, application, and region. Based on the mechanism of action, the global anti-viral therapies market is classified into protease inhibitors, reverse transcriptase inhibitors, nucleotide polymerase inhibitor, and others. The type segment is divided into branded drugs and generic drugs. The application segment consists of influenza, herpes virus, hepatitis, HIV, and others.

Anti-Viral Therapies Market: Report Scope

Global Anti-Viral Therapies Market: Regional Analysis

North America is expected to hold a prominent share in the global anti-viral therapies market and it’s anticipated the region will continue its dominance in the market over the forecast period. North America is among the highest purchaser of biological drugs and demand for antiviral drugs is always high in the region owing to large patient numbers suffering from HIV, influenza, hepatitis A, hepatitis B, and hepatitis C. In addition, high awareness regarding antiviral therapeutics is fuelling the market growth in North America. Asia Pacific is expected to be the most lucrative market for anti-viral therapies. The increasing prevalence of viral diseases in the region is among the major factor driving the growth of the market.

Global Anti-Viral Therapies Market: Competitive Players

Some of the predominant players that are operating in the global anti-viral therapies market include

• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Johnson & Johnson
• Aurobindo Pharma Limited
• AbbVie Inc.
• AstraZeneca plc
• Abbott Laboratories
• Bristol-Myers-Squibb
• GlaxoSmithKline
•  Gilead Sciences.

The global Anti-Viral Therapies Market is segmented as follows:

By Mechanism of action 

• protease inhibitors
• reverse transcriptase inhibitors
• nucleotide polymerase inhibitor 
• others 

By Type

• branded drugs 
• generic drugs

By Application 

• influenza
• herpes virus
• hepatitis
• HIV
• others

Global Anti-Viral Therapies Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.